4//SEC Filing
Camardo Daniel A. 4
Accession 0001209191-21-025270
CIK 0001492426other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:25 PM ET
Size
14.6 KB
Accession
0001209191-21-025270
Insider Transaction Report
Form 4
Camardo Daniel A.
EVP and President, U.S.
Transactions
- Exercise/Conversion
Ordinary shares
2021-04-05$15.23/sh+509$7,752→ 51,181 total - Exercise/Conversion
Employee stock option (right to buy)
2021-04-05−2,305→ 0 totalExercise: $17.19Exp: 2027-02-21→ Ordinary shares (2,305 underlying) - Exercise/Conversion
Employee stock option (right to buy)
2021-04-05−509→ 3,441 totalExercise: $15.23Exp: 2026-05-03→ Ordinary shares (509 underlying) - Exercise/Conversion
Ordinary shares
2021-04-05$17.19/sh+2,305$39,623→ 35,205 total - Exercise/Conversion
Ordinary shares
2021-04-05$25.52/sh+15,467$394,718→ 50,672 total - Exercise/Conversion
Employee stock option (right to buy)
2021-04-05−15,467→ 4,333 totalExercise: $25.52Exp: 2025-09-22→ Ordinary shares (15,467 underlying)
Footnotes (1)
- [F1]The option is fully vested and exercisable.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001820365
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:25 PM ET
- Size
- 14.6 KB